Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01286155 · ClinicalTrials.gov registry record

Epidemiology of Barrett's Esophagus: A Population Based Study

A clinical trial, sponsored by Mayo Clinic.

Completed
Registry status
534
Enrollment target

NCT01286155: Completed study, sponsored by Mayo Clinic.

NCT01286155 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 534 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01286155 has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
534 participants
Enrollment target

Study Summary

To assess attitudes toward screening for esophageal adenocarcinoma (EAC) and Barrett's esophagus (BE) in the community. To develop a population based clinical risk factor prediction model for the diagnosis of BE and identify novel risk factors for BE which would make population based screening more efficient. This will be an important first step in identifying the target population for BE screening, another crucial component of making screening feasible and efficient

Trial Details

FieldValue
Enrollment Target 534 participants
Start Date 2010-01
Est. Completion 2011-06

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT01286155

The ClinicalTrials.gov registry entry for NCT01286155 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 534 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01286155 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01286155 about?

NCT01286155 is a clinical study titled "Epidemiology of Barrett's Esophagus: A Population Based Study". To assess attitudes toward screening for esophageal adenocarcinoma (EAC) and Barrett's esophagus (BE) in the community. To develop a population based clinical risk factor prediction model for the diagnosis of BE and identify novel risk factors for BE which would make population based screening more...

What is the current status of trial NCT01286155?

This trial is currently completed. The enrollment target is 534 participants. The study started on 2010-01. Estimated completion is 2011-06.

Who is sponsoring clinical trial NCT01286155?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.